Companhia de Saneamento Basico do Estado de Sao Paulo SABESP ADR (SBS)

This article lists various ETFs that hold Companhia de Saneamento Basico do Estado de Sao Paulo SABESP Sponsored ADR stocks. It provides a detailed table including each fund's market value, weight, issuer, management style, focus, expense ratio, AUM, price, change, relative volume, and 3-year NAV total return. The ETFs listed range from those focused on international equity and global infrastructure to water resources and emerging markets.

Companhia de Saneamento Básico do Estado de São Paulo (SBS) shares have risen by 3.36% due to favorable regulatory developments, with price action tightening into a narrow weekly range around $4.60. The stock shows modest valuation with a P/E under 10 and P/S around 2.2, along with solid pre-tax margins and ROIC for a regulated utility. Traders are focusing on the stable range setup, with key tactical levels identified for potential breakouts or breakdowns.

Companhia de Saneamento Basico Do Estado De Sao Paulo (SBS) stock is trading in a tight range, reflecting consolidation as traders await new catalysts despite positive regulatory prospects. The stock's modest valuation (P/E under 10, P/S just over 2) and solid fundamentals, including moderate leverage and a stable dividend yield, make it attractive to value-focused investors. Technical analysis indicates strong support at $4.45, with analysts suggesting accumulation on dips and a medium-term price target of $5.50.

The average 12-month price target for Companhia de Saneamento Basico Do Estado De Sao Paulo - Sabesp (SBSP3) stock has been lowered from $6.78 to $6.71 by analysts, with a range of $4.7 to $7.71. This updated target suggests a potential 48% upside based on the Aug. 18 closing price. The consensus rating from 12 analysts remains "Buy," with 11 Buy ratings, 0 Holds, and 1 Sell.

Bank of America Corp DE significantly reduced its stake in Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp (NYSE:SBS) by 60.5% in the first quarter, selling over 1.3 million shares. Despite this, other institutional investors like Jane Street, JPMorgan, Russell Investments, and Invesco increased their holdings, with institutions collectively owning 10.62% of the stock. Analyst sentiment remains a "Moderate Buy" with a consensus target price of $183, even though recent quarterly results missed revenue and EPS expectations.